Show simple item record

dc.contributor.authorManktelow, CJ
dc.contributor.authorPenkova, E
dc.contributor.authorScott, L
dc.contributor.authorMatthews, A
dc.contributor.authorRaymond, B
dc.date.accessioned2020-07-20T14:46:09Z
dc.date.issued2020-07-13
dc.description.abstractThe acquisition of antibiotic resistance commonly imposes fitness costs, a reduction in the fitness of bacteria in the absence of drugs. These costs have been primarily quantified using in vitro experiments and a small number of in vivo studies in mice, and it is commonly assumed that these diverse methods are consistent. Here, we used an insect model of infection to compare the fitness costs of antibiotic resistance in vivo relative to in vitro conditions. Experiments explored diverse mechanisms of resistance in a Gram-positive pathogen, Bacillus thuringiensis, and a Gram-negative intestinal symbiont, Enterobacter cloacae. Rifampicin resistance in B. thuringiensis showed fitness costs that were typically elevated in vivo, although these were modulated by genotype-environment interactions. In contrast, resistance to cefotaxime via de-repression of AmpC β-lactamase in E. cloacae resulted in undetectable costs in vivo or in vitro, while spontaneous resistance to nalidixic acid, and carriage of the IncP plasmid RP4, imposed costs that increased in vivo. Overall, fitness costs in vitro were a poor predictor of fitness costs in vivo because of strong genotype environment interactions throughout this study. Insect infections provide a cheap and accessible means of assessing fitness consequences of resistance mutations, data that is important to understand the evolution and spread of resistance. This study emphasizes that the fitness costs imposed by particular mutations or different modes of resistance are extremely variable, and that only a subset of these mutations are likely to be prevalent outside of the laboratory.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.formatData are tab delimited text filesen_GB
dc.identifier.citationPublished online 13 July 13 2020en_GB
dc.identifier.doi10.1128/AAC.01033-20
dc.identifier.grantnumberMR/N013824/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/122033
dc.language.isoenen_GB
dc.publisherAmerican Society for Microbiologyen_GB
dc.relation.urlhttps://doi.org/10.24378/exe.2503en_GB
dc.rights.embargoreasonUnder embargo until 13 January 2021 in compliance with publisher policy.en_GB
dc.rightsCopyright © 2020 American Society for Microbiology. All Rights Reserved.en_GB
dc.subjectfitness costen_GB
dc.subjectinsect modelsen_GB
dc.subjectantibiotic resistanceen_GB
dc.subjectantimicrobial stewardshipen_GB
dc.subjectantimicrobial susceptibilityen_GB
dc.subjectE. cloacaeen_GB
dc.subjectpleiotropic costen_GB
dc.subjectB. thuringiensisen_GB
dc.titleStrong environment X genotype interactions determine the fitness costs of antibiotic resistance in vitro and in an insect model of infection (article)en_GB
dc.typeArticleen_GB
dc.date.available2020-07-20T14:46:09Z
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Society for Microbiology via the DOI in this record.en_GB
dc.descriptionThe dataset associated with this article is located in ORE at: https://doi.org/10.24378/exe.2503en_GB
dc.identifier.journalAntimicrobial agents and chemotherapyen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2020-07-08
exeter.funder::Medical Research Council (MRC)en_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2020-07-08
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-07-20T14:35:24Z
refterms.versionFCDAM
refterms.dateFOA2021-01-13T00:00:00Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record